Heparin-Binding Epidermal Growth Factor-Like Growth Factor and Mesenchymal Stem Cells Act Synergistically to Prevent Experimental Necrotizing Enterocolitis - 14/09/12
Correspondence address: Gail E Besner, MD, FACS, Nationwide Children's Hospital, Department of Surgery ED 321, 700 Children's Dr, Columbus, OH 43205Résumé |
Background |
We have shown that administration of heparin-binding EGF (epidermal growth factor)-like growth factor (HB-EGF) protects the intestines from experimental necrotizing enterocolitis (NEC). We have also demonstrated that systemically administered mesenchymal stem cells (MSC) can engraft into injured intestines. This study investigated the effects of HB-EGF on MSC in vitro, and whether MSC and HB-EGF can act synergistically to prevent NEC in vivo.
Study Design |
In vitro, the effect of HB-EGF on MSC proliferation, migration, and apoptosis was determined. In vivo, rat pups received MSC either intraperitoneally (IP) or intravenously (IV). Pups were assigned to 1 of 7 groups: Group 1, breast-fed; Group 2, experimental NEC; Group 3, NEC+HB-EGF; Group 4, NEC+MSC IP; Group 5, NEC+HB-EGF+MSC IP; Group 6, NEC+MSC IV; or Group 7, NEC+HB-EGF+MSC IV. Mesechymal stem cell engraftment, histologic injury, intestinal permeability, and mortality were determined.
Results |
Heparin-binding EGF-like growth factor promoted MSC proliferation and migration, and decreased MSC apoptosis in vitro. In vivo, MSC administered IV had increased engraftment into NEC-injured intestine compared with MSC administered IP (p < 0.05). Heparin binding EGF-like growth factor increased engraftment of IP-administered MSC (p < 0.01) and IV-administered MSC (p < 0.05). Pups in Groups 3 to 7 had a decreased incidence of NEC compared with nontreated pups (Group 2), with the lowest incidence in pups treated with HB-EGF+MSC IV (p < 0.01). Pups in Group 7 had a significantly decreased incidence of intestinal dilation and perforation, and had the lowest intestinal permeability, compared with other treatment groups (p < 0.01). Pups in all experimental groups had significantly improved survival compared with pups exposed to NEC, with the best survival in Group 7 (p < 0.05).
Conclusions |
Heparin-binding EGF-like growth factor and MSC act synergistically to reduce injury and improve survival in experimental NEC.
Le texte complet de cet article est disponible en PDF.Abbreviations and Acronyms : DAPI, D-MEM, FD, HB-EGF, IP, MSC, NEC, YFP
Plan
| Disclosure Information: Nothing to disclose. |
|
| This work is supported by NIH R01 DK74611 and NIH R01 GM61193 (GEB). |
Vol 215 - N° 4
P. 534-545 - octobre 2012 Retour au numéro
Article précédent
- Effectiveness of a Radiofrequency Detection System as an Adjunct to Manual Counting Protocols for Tracking Surgical Sponges: A Prospective Trial of 2,285 Patients
- Christopher C. Rupp, Mary J. Kagarise, Stella M. Nelson, Allison M. Deal, Susan Phillips, Janet Chadwick, Tamara Petty, Anthony A. Meyer, Hong Jin Kim
- Intraoperative Pathologic Examination in the Era of Molecular Testing for Differentiated Thyroid Cancer
- Kelly L. McCoy, Sally E. Carty, Michaele J. Armstrong, Raja R. Seethala, N. Paul Ohori, Adam S. Kabaker, Michael T. Stang, Steven P. Hodak, Yuri E. Nikiforov, Linwah Yip
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?